Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Ronchetti, Domenica ^a   Mosca, Laura ^a   Cutrona, Giovanna ^b   Tuana, Giacomo ^a   Gentile, Massimo ^c   Fabris, Sonia ^a   Agnelli, Luca ^a   Ciceri, Gabriella ^a   Matis, Serena ^b   Massucco, Carlotta ^b   Colombo, Monica ^b   Reverberi, Daniele ^b   Recchia, Anna Grazia ^c   Bossio, Sabrina ^c   Negrini, Massimo ^d   Tassone, Pierfrancesco ^e   Morabito, Fortunato ^c   Ferrarini, Manlio ^b   Neri, Antonino ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Azienda Ospedaliera di Cosenza   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD19 ANTIGEN; CD38 ANTIGEN; PROTEIN KINASE ZAP 70; SMALL NUCLEOLAR RNA; SMALL NUCLEOLAR RNA 31; SMALL NUCLEOLAR RNA 6; SMALL NUCLEOLAR RNA 62; SMALL NUCLEOLAR RNA 71C; SMALL NUCLEOLAR RNA 74A; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CANCER STAGING; CD19+ B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; COBLL1 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GERMINAL CENTER; HUMAN; HUMAN CELL; IGHV GENE; MAJOR CLINICAL STUDY; MEMORY CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONSIL;

B-LYMPHOCYTE SUBSETS; CELL NUCLEUS; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOPLASM STAGING; PROGNOSIS; RISK; RNA, SMALL NUCLEOLAR; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84883730526     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-27     Document Type: Article

References (49)

1. Chronic lymphocytic leukemia. Chiorazzi N, Rai KR, Ferrarini M, N Engl J Med 2005 352 804 815 10.1056/NEJMra041720 15728813 (Pubitemid 40271175)
2. Chronic lymphocytic leukemia: staging and prognostic factors. Zwiebel JA, Cheson BD, Semin Oncol 1998 25 42 59 9535211 (Pubitemid 28090911)
3. Clinical staging of chronic lymphocytic leukemia. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS, Blood 1975 46 219 234 1139039
4. Investigation of a new parameter in chronic lymphocytic leukemia: the percentage of large peripheral lymphocytes determined by the hemalog D. Prognostic significance. Binet JL, Vaugier G, Dighiero G, D'Athis P, Charron D, Am J Med 1977 63 683 688 10.1016/0002-9343(77)90152-8 930943 (Pubitemid 8222932)
5. Prognostic factors in chronic lymphocytic leukemia. Kay NE, Shanafelt TD, Curr Hematol Malig Rep 2007 2 49 55 10.1007/s11899-007-0007-1 20425388 (Pubitemid 46953001)
6. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E, N Engl J Med 2003 348 1764 1775 10.1056/NEJMoa023143 12724482 (Pubitemid 36514707)
7. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N, Blood 1999 94 1840 1847 10477712 (Pubitemid 29430399)
8. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK, Blood 1999 94 1848 1854 10477713 (Pubitemid 29430400)
9. Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab. Byrd JC, Smith L, Hackbarth ML, Flinn IW, Young D, Proffitt JH, Heerema NA, Cancer Res 2003 63 36 38 12517774 (Pubitemid 36070416)
10. p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Blood 1995 85 1580 1589 7888675
11. Genomic aberrations and survival in chronic lymphocytic leukemia. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P, N Engl J Med 2000 343 1910 1916 10.1056/NEJM200012283432602 11136261 (Pubitemid 32064784)
12. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T, Leukemia 2007 21 2442 2451 10.1038/sj.leu.2404935 17805327 (Pubitemid 350148886)
13. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Stilgenbauer S, Bullinger L, Lichter P, Dohner H, Leukemia 2002 16 993 1007 10.1038/sj.leu. 2402537 12040431 (Pubitemid 34618838)
14. Non-coding RNAs: regulators of disease. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS, J Pathol 2010 220 126 139 10.1002/path.2638 19882673
15. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Kiss T, Cell 2002 109 145 148 10.1016/S0092-8674(02)00718-3 12007400 (Pubitemid 34518252)
16. Are snoRNAs and snoRNA host genes new players in cancer? Williams GT, Farzaneh F, Nat Rev Cancer 2012 12 84 88 22257949
17. Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. Chu L, Su MY, Maggi LB Jr, Lu L, Mullins C, Crosby S, Huang G, Chng WJ, Vij R, Tomasson MH, J Clin Invest 2012 122 2793 2806 10.1172/JCI63051 22751105
18. Genomic analysis of high risk smoldering multiple myeloma. Lopez-Corral L, Mateos MV, Corchete LA, Sarasquete ME, la RJ D, De AF, Lahuerta JJ, Garcia-Sanz R, San Miguel JF, Gutierrez NC, Haematologica 2012 97 1439 1443 10.3324/haematol.2011.060780 22331267
19. The expression pattern of small nucleolar and small cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Ronchetti D, Todoerti K, Tuana G, Agnelli L, Mosca L, Lionetti M, Fabris S, Colapietro P, Miozzo M, Ferrarini M, Tassone P, Neri A, Blood Cancer J 2012 2 96 10.1038/bcj.2012.41 23178508
20. Expression of small nucleolar RNAs in leukemic cells. Teittinen KJ, Laiho A, Uusimaki A, Pursiheimo JP, Gyenesei A, Lohi O, Cell Oncol (Dordr) 2013 36 55 63 10.1007/s13402-012-0113-5
21. Specific small nucleolar RNA expression profiles in acute leukemia. Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, Agirre X, Prosper F, Kiss T, Brousset P, Leukemia 2012 26 2052 2060 10.1038/leu.2012.111 22522792
22. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, De LL, Gisselbrecht C, Gaulard P, Brousset P, Blood 2012 8 3997 4005
23. National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR, Blood 1996 87 4990 4997 8652811 (Pubitemid 26189840)
24. B lymphocytes in humans express ZAP-70 when activated in vivo. Cutrona G, Colombo M, Matis S, Reverberi D, Dono M, Tarantino V, Chiorazzi N, Ferrarini M, Eur J Immunol 2006 36 558 569 10.1002/eji.200526355 16482508
25. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, Vigna E, Gentile M, Zupo S, Chiorazzi N, Morabito F, Ferrarini M, Haematologica 2008 93 413 422 10.3324/haematol.11646 18287138 (Pubitemid 351398643)
26. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, Matis S, Colombo M, Agnelli L, Gentile M, Spriano M, Callea V, Festini G, Molica S, Lambertenghi DG, Morabito F, Ferrarini M, Neri A, Genes Chromosomes Cancer 2008 47 781 793 10.1002/gcc.20579 18521849
27. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. Maura F, Cutrona G, Fabris S, Colombo M, Tuana G, Agnelli L, Matis S, Lionetti M, Gentile M, Recchia AG, Di RF, Musolino C, Ilariucci F, Di RN, Pesce E, Molica S, Federico M, Cortelezzi A, Morabito F, Ferrarini M, PLoS One 2011 6 24313 10.1371/journal.pone.0024313 21897877
28. Definition of progression risk based on combinations of cellular and molecular markers in patients with binet stage a chronic lymphocytic leukaemia. Morabito F, Cutrona G, Gentile M, Matis S, Todoerti K, Colombo M, Sonaglio C, Fabris S, Reverberi D, Megna M, Spriano M, Lucia E, Rossi E, Callea V, Mazzone C, Festini G, Zupo S, Molica S, Neri A, Ferrarini M, Br J Haematol 2009 146 44 53 10.1111/j.1365-2141.2009.07703.x 19438486
29. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP, Biostatistics 2003 4 249 264 10.1093/biostatistics/4.2.249 12925520
30. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F, Nucleic Acids Res 2005 33 175 10.1093/nar/gni179 16284200 (Pubitemid 41806403)
31. Improved precision and accuracy for microarrays using updated probe set definitions. Sandberg R, Larsson O, BMC Bioinforma 2007 8 48 10.1186/1471-2105-8-48 (Pubitemid 46358096)
32. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci USA 2001 98 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
33. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. Schadt EE, Li C, Ellis B, Wong WH, J Cell Biochem Suppl 2001 37 120 125 11842437
34. Sno/scaRNAbase: a curated database for small nucleolar RNAs and cajal body-specific RNAs. Xie J, Zhang M, Zhou T, Hua X, Tang L, Wu W, Nucleic Acids Res 2007 35 183 D187 10.1093/nar/gkl873 17099227 (Pubitemid 46056195)
35. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Chiorazzi N, Ferrarini M, Blood 2011 117 1781 1791 10.1182/blood-2010-07-155663 21148333
36. Cellular origin and pathophysiology of chronic lymphocytic leukemia. Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Durig J, Kuppers R, J Exp Med 2012 209 2183 2198 10.1084/jem.20120833 23091163
37. TPT1/ TCTP-regulated pathways in phenotypic reprogramming. Amson R, Pece S, Marine JC, Di Fiore PP, Telerman A, Trends Cell Biol 2013 23 37 46 10.1016/j.tcb.2012.10.002 23122550
38. High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia. Friedrichs B, Siegel S, Reimer R, Barsoum A, Coggin J Jr, Kabelitz D, Heidorn K, Schulte C, Schmitz N, Zeis M, Leuk Res 2011 35 721 729 10.1016/j.leukres.2010.10.002 21055809
39. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology. Abruzzo LV, Barron LL, Anderson K, Newman RJ, Wierda WG, O'Brien S, Ferrajoli A, Luthra M, Talwalkar S, Luthra R, Jones D, Keating MJ, Coombes KR, J Mol Diagn 2007 9 546 555 10.2353/jmoldx.2007.070001 17690214 (Pubitemid 47434122)
40. Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia. Mansouri L, Gunnarsson R, Sutton LA, Ameur A, Hooper SD, Mayrhofer M, Juliusson G, Isaksson A, Gyllensten U, Rosenquist R, Am J Hematol 2012 87 737 740 10.1002/ajh.23227 22674506
41. Cordon-bleu is a conserved gene involved in neural tube formation. Carroll EA, Gerrelli D, Gasca S, Berg E, Beier DR, Copp AJ, Klingensmith J, Dev Biol 2003 262 16 31 10.1016/S0012-1606(03)00323-3 14512015 (Pubitemid 37153102)
42. Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro. Gordon GJ, Bueno R, Sugarbaker DJ, BMC Cancer 2011 11 169 10.1186/1471-2407-11-169 21569526
43. Molecular pathogenesis of chronic lymphocytic leukemia. Gaidano G, Foa R, La-Favera R, J Clin Invest 2012 122 3432 3438 10.1172/JCI64101 23023714
44. Human U19 intron-encoded snoRNA is processed from a long primary transcript that possesses little potential for protein coding. Bortolin ML, Kiss T, RNA 1998 4 445 454 9630250 (Pubitemid 28160785)
45. Matrin 3 binds and stabilizes mRNA. Salton M, Elkon R, Borodina T, Davydov A, Yaspo ML, Halperin E, Shiloh Y, PLoS One 2011 6 23882 10.1371/journal.pone.0023882 21858232
46. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K, Hum Mol Genet 2001 10 2687 2700 10.1093/hmg/10.23.2687 11726556 (Pubitemid 33133410)
47. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, Stefan M, Beach C, Nicholls RD, Zavolan M, Stamm S, Hum Mol Genet 2010 19 1153 1164 10.1093/hmg/ddp585 20053671
48. snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions. Bazeley PS, Shepelev V, Talebizadeh Z, Butler MG, Fedorova L, Filatov V, Fedorov A, Gene 2008 408 172 179 10.1016/j.gene.2007.10. 037 18160232
49. SF3B1 And other novel cancer genes in chronic lymphocytic leukemia. Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, N Engl J Med 2011 365 2497 2506 10.1056/NEJMoa1109016 22150006